F

Amicus Therapeutics
D

FOLD

9.57000
USD
-0.31
(-3.14%)
مغلق
حجم التداول
83,746
الربح لكل سهم
-0
العائد الربحي
-
P/E
-28
حجم السوق
2,859,571,248
أصول ذات صلة
    A
    ARWR
    -1.900
    (-8.54%)
    20.340 USD
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    N
    NTLA
    -1.110
    (-8.45%)
    12.020 USD
    Q
    QURE
    -0.750
    (-4.55%)
    15.740 USD
    S
    SGMO
    -0.48000
    (-17.02%)
    2.34000 USD
    S
    SRPT
    -5.630
    (-4.47%)
    120.200 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.